ROBERT SEXTON: Open Payments
NPI 1952656829 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 29 payments from 14 companies in 2025. Trend: 2023 $1,157 · 2024 $782 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $112 |
| Astellas Pharma US Inc | 4 | $101 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Amgen Inc. | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Boston Scientific Corporation | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: Veozah, TRELEGY ELLIPTA, QULIPTA, VRAYLAR, EVENITY, CAPLYTA, FARXIGA, General - Erectile Dysfunction.
Industry payments across TN — which companies pay providers there.
